Clinical Trial Update: Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patients? [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigates whether an extra-high dose of hepatitis B vaccine can provide longer-lasting serological protection in patients undergoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Peritoneal Dialysis

Drugs mentioned

• Hepatitis B vaccine (Hepatitis B vaccine)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Peritoneal Dialysis, Renal Disease, End-Stage | Phase 4 | Status: COMPLETED